Showing results (261-270 of 583) with videos related to
Sort By:
Pageof 59
Langmuir : the ACS Journal of Surfaces and Colloids|May 1, 2023
Tribology of Pore-Textured Hard Surfaces under Physiological Conditions: Effects of Texture ScalesYiwen Xi, Chang-Hwan Choi, Robert Chang, et al.Gene|June 11, 1997
Longus pilus of enterotoxigenic Escherichia coli and its relatedness to other type-4 pili--a minireviewJ A Girón, O G Gómez-Duarte, K G Jarvis, et al.Journal of the Mechanical Behavior of Biomedical Materials|July 6, 2025
Glycosaminoglycan depletion lowers the crack resistance of articular cartilage under impact loadingKe Ren, Fenghua Zhao, Natalia K Tzaneti, et al.Plant Disease|March 13, 2019
Viral Satellite RNA Expression in Transgenic Tomato Confers Field Tolerance to Cucumber Mosaic VirusJohn R Stommel, Marie E Tousignant, Thanda Wai, et al.Vaccine|December 1, 1990
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adultsS J Cryz, M M Levine, J B Kaper, et al.FEMS Microbiology Letters|July 15, 1993
Construction of genetically marked Vibrio cholerae O1 vaccine strainsJ M Ketley, J Michalski, J Galen, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coliT R Hirst, J Sanchez, J B Kaper, et al.Vaccine|August 23, 2005
Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strainChengru Zhu, Shuzhang Feng, Timothy E Thate, et al.Journal of Dentistry|December 14, 2024
Health literacy, oral diseases, and contributing pathways: results from the Lifelines Cohort StudyTrishnika Chakraborty, Marise S Kaper, Josue Almansa, et al.Biochemical and Biophysical Research Communications|February 22, 2005
3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferationDavid K R Karaolis, Kunrong Cheng, Michael Lipsky, et al.Pageof 59